SCHEMBL13076451

SCHEMBL13076451

O=CNCCNCc1ccc(CN2CCCNCCNCCCNCC2)cc1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 13/20 0.67
MEN1 O00255 1/20 0.63
CHRM2 P08172 1/20 0.63
CHRM1 P11229 1/20 0.63
ADRA2C P18825 1/20 0.63
CCR2 P41597 1/20 0.63
CXCL12 P48061 1/20 0.63
BLM P54132 1/20 0.63
KMT2A Q03164 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
HRH3 Q9Y5N1 1/20 0.63
MCHR1 Q99705 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
SIGMAR1 Q99720 2/20 0.42
NCF1 P14598 1/20 0.40
HTR5A P47898 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14640067 0.84 CXCR4 (0.72) CXCR4MEN1CHRM2CHRM1ADRA2C
Bromide SCHEMBL9709602 0.83 CXCR4 (0.67) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL13077386 0.82 CXCR4 (0.63) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL24677400 0.81 CXCR4 (0.56) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL14640063 0.81 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
Bromide SCHEMBL9709490 0.80 CXCR4 (0.63) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL29490414 0.80 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
Plerixafor SCHEMBL19038 0.80 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL5611617 0.80 CXCR4 (1.00) CXCR4MEN1CHRM2CHRM1ADRA2C
SCHEMBL14640062 0.80 CXCR4 (0.78) CXCR4MEN1CHRM2CHRM1ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010126888-A1 HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS GLYCOMIMETICS, INC. (US) 2010-11-04 WO disclosed